ENMC Encore Medical

AUSTIN, Texas, Dec. 1 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) announced today that Kenneth W. Davidson, CEO and Chairman of the Board of Directors, and other members of Encore's Executive Management, will present at the First Albany Annual Growth Conference on Tuesday, December 6, 2005, at 3:20p.m. EST. The conference is being held at The Mandarin Oriental Hotel in New York City. The presentation will provide an overview of Encore's products, market opportunities and competitive position. A live webcast of the presentation can be accessed through the Encore Medical website http://www.encoremed.com/ . Simply click on the link for the First Albany Growth Conference webcast on the opening page. The webcast will be archived for two weeks. Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices, including surgical implants, sports medicine equipment and products for orthopedic rehabilitation, pain management and physical therapy. Based in Austin, Texas, Encore's products are used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries, and our non-invasive medical devices and related accessories are primarily used by patients for at-home physical therapy. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products, trauma products and spinal implants. Through our Orthopedic Rehabilitation Division, Encore is a leading manufacturer and distributor of orthopedic rehabilitation equipment in the United States. For more information, visit http://www.encoremed.com/ . Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties, such as quarterly fluctuations in operating results, the timely availability of new products, the impacts of competitive products and pricing, the ability to continue to obtain long-term financing, and the ability to locate and integrate future acquisitions and other risks and uncertainties set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. For: Encore Medical Corporation Contact: Davis Henley Vice President - Business Development (512) 832-9500 DATASOURCE: Encore Medical Corporation CONTACT: Davis Henley, Vice President - Business Development of Encore Medical Corporation, +1-512-832-9500 Web site: http://www.encoremed.com/

Copyright